ZYVERSA THERAPEUTICS, INC. Other Non-Current Assets
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Other Non-Current Assets of $18.65 million as of 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-03-31
- 2025-03-31: Other Assets, Noncurrent $18.65M.
- 2024-12-31: Other Assets, Noncurrent $18.65M.
- 2024-09-30: Other Assets, Noncurrent $18.65M.
- 2024-06-30: Other Assets, Noncurrent $18.65M.
| Period end | Other Assets, Noncurrent |
|---|---|
| 2025-03-31 | $18.65M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $18.65M 10-K · filed 2026-03-31 |
| 2024-09-30 | $18.65M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $18.65M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $18.65M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $18.65M 10-K · filed 2025-03-27 |
| 2023-06-30 | $30.81M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $100.09M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $100.09M 10-K · filed 2024-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |